Amlodipine Besylate Tablet
Product Images NDC 71610-888
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena (Aphena)
Chemical Structure (Image 1)
\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig01.jpg)
\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig02.jpg)
This information appears to present results from a study comparing the effects of Amlodipine and Placebo on various parameters, such as Vessel Disease, Vessel Stenosis, and PCI (Percutaneous Coronary Intervention). The data points to certain factors favoring Amlodipine over Placebo, as indicated by the headings "Favors Amlodipine" and "Favors Placebo". The baseline Systolic Blood Pressure (SBP) was noted to be 129 mmHg. However, further details on the study design, outcomes, and statistical analysis are not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.